ABSTRACT
Perinatal mental health disorders, such as depression and anxiety, are highly prevalent and can have severe consequences on maternal morbidity and mortality, and on infant neurodevelopment. Yet, the biological mechanisms of these disorders are underexplored, especially in Black, Indigenous, and People of Color (BIPOC) populations. Here, we aim to investigate functional brain alterations across the perinatal period using portable electroencephalography (pEEG) in a diverse cohort of pregnant individuals reporting symptoms of depression or anxiety. Participants (61 subjects, 45% Non-Hispanic Black and 32% Hispanic) were followed longitudinally from early pregnancy through postpartum. Brain electrical activity was quantified with pEEG (61 subjects, 209 pEEG recordings) and mental health was assessed using the PHQ-9 and GAD-7 at multiple time points throughout the perinatal period. Using linear models and linear mixed models, our preliminary findings suggest significant changes in brain wave activity, such as alpha and delta waves, are associated with depression and anxiety severity during the perinatal period. The study addresses critical gaps in understanding perinatal mental health in racially, ethnically, and socioeconomically diverse populations, with the goal of developing sensitive clinically feasible diagnostic tools to mitigate health disparities.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This project was funded by the Yong Investigator Award Brain and Behavior Research Foundation to BPB (BPB) and the BIRCWH K12 Award to BPB (K12AR084225).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Office for the Protection of Research Subjects of University of Illinois at Chicago gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* Co-first Authors
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.